2 completed, 2 terminated. 2 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Tetradecanoylphorbol Acetate: new trials by email Literature Review of Tetradecanoylphorbol Acetate trials Research Report on Tetradecanoylphorbol Acetate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| t-PA Prophylaxis to Prevent Catheter-associated Thrombosis and Infection alteplase (recombinant t-PA), Heparin - Central Venous Catheter Thrombosis, Central Venous Catheter Associated Bloodstream Infection | Phase 2 | Completed | Medical College of Wisconsin | 20 | 2019-04-22 | 2021-07-13 |
| Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies 12-O-tetradecanoylphorbol-13-acetate, Dexamethasone, Choline magnesium trisalicylate - Leukemia | Phase 2 | Terminated | Rutgers, The State University of New Jersey | 1 | 2011-03-01 | 2015-11-04 |
| IV vs. IA tPA (Activase) in Acute Ischemic Stroke With CTA Evidence of Major Vessel Occlusion IV tpa (Alteplase) vs IA tpa (Alteplase) - Ischemic Stroke | Not applicable | Completed | University of North Carolina, Chapel Hill | 7 | 2004-03-01 | 2011-11-08 |
| 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder tetradecanoylphorbol acetate - Chronic Myeloproliferative Disorders, Leukemia | Phase 1 | Terminated | University of Medicine and Dentistry of New Jersey | 1998-12-01 | 2010-01-26 |
Leukemia (2) · Leukemia, Myeloid, Acute (2) · Anemia, Refractory (1) · Anemia, Refractory, with Excess of Blasts (1) · Burkitt Lymphoma (1) · Congenital Abnormalities (1) · Hodgkin Disease (1) · Immunoblastic Lymphadenopathy (1) · Immunoglobulin Light-chain Amyloidosis (1) · Ischemic Stroke (1) · Leukemia, Biphenotypic, Acute (1) · Leukemia, Hairy Cell (1) · Leukemia, Large Granular Lymphocytic (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (1)
Medical College of Wisconsin (1) · Rutgers, The State University of New Jersey (1) · University of Medicine and Dentistry of New Jersey (1) · University of North Carolina, Chapel Hill (1)
United States (4)
Roger Strair, MD, PhD (2) · Souvik Sen, MD (1)
P30CA072720 (2), P30CA068485 (1)